Skip to main content Accessibility help
×
Hostname: page-component-7479d7b7d-rvbq7 Total loading time: 0 Render date: 2024-07-12T04:03:40.716Z Has data issue: false hasContentIssue false

Atomoxetine

Published online by Cambridge University Press:  19 October 2021

Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Prescriber's Guide
Stahl's Essential Psychopharmacology
, pp. 79 - 84
Publisher: Cambridge University Press
Print publication year: 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Suggested Reading

Garnock-Jones, KP, Keating, GM. Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents. Paediatr Drugs 2009;11(3):203–26.CrossRefGoogle ScholarPubMed
Kelsey, D, Sumner, C, Casat, C, et al. Once daily atomoxetine treatment for children with attention deficit hyperactivity behavior including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial. Pediatrics 2004;114:el–8.CrossRefGoogle ScholarPubMed
Michelson, D, Adler, L, Spencer, T, et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 2003;53(2):112–20.CrossRefGoogle ScholarPubMed
Michelson, D, Buitelaar, JK, Danckaerts, M, et al. Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 2004;43(7):896904.CrossRefGoogle ScholarPubMed
Stiefel, G, Besag, FM. Cardiovascular effects of methylphenidate, amphetamines, and atomoxetine in the treatment of attention-deficit hyperactivity disorder. Drug Saf 2010;33(10):821–42.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Atomoxetine
  • Stephen M. Stahl, University of California, San Diego
  • Book: Prescriber's Guide
  • Online publication: 19 October 2021
  • Chapter DOI: https://doi.org/10.1017/9781108921275.013
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Atomoxetine
  • Stephen M. Stahl, University of California, San Diego
  • Book: Prescriber's Guide
  • Online publication: 19 October 2021
  • Chapter DOI: https://doi.org/10.1017/9781108921275.013
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Atomoxetine
  • Stephen M. Stahl, University of California, San Diego
  • Book: Prescriber's Guide
  • Online publication: 19 October 2021
  • Chapter DOI: https://doi.org/10.1017/9781108921275.013
Available formats
×